4d Pharma PLC Annual Report and Notice of AGM

4D pharma plc (LON:DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, today announced that the Annual Report and Accounts for the year to 31 December 2017 and Notice of the Company’s Annual General Meeting (“AGM”) have been posted to shareholders.

An electronic copy of each of the Annual Report and Accounts and the Notice of AGM is available on the Company’s website, www.4dpharmaplc.com.

The AGM will be held on Monday 21 May 2018 at 11 a.m. at the Gridiron Building, 1 Pancras Square, London N1C 4AG.

 

Founded in February 2014, 4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.  4D has developed a proprietary platform that rationally identifies novel bacteria that have a precise and evolved therapeutic effect.  All of 4D’s live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut.  4D has completed a phase I study in Irritable Bowel Syndrome and has recently completed dosing in a phase I study in Paediatric Crohn’s Disease.  It currently has a pipeline of 13 pre-clinical programmes, covering disease areas such as cancer, poorly controlled asthma, autoimmune and CNS disease, and plans to commence four additional clinical studies in 2018.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    4d Pharma Plc

    More articles like this

    4d Pharma Plc

    How Exercise Improves Gut Bacteria

    An endeavour to boost gut health is an endeavour to boost overall mental and physical well-being. While food is important for gut health, lifestyle also plays a role. Designing your home to be chemical free (e.g

    4d Pharma Plc

    How Gut Bacteria May Be Linked to Lupus

    Women with lupus had higher amounts of a specific bacterium in their gut, along with increased levels of an antibody to that bacterium. Bacteria and other microorganisms living in your gut, known as the microbiome, play

    4d Pharma Plc

    4D pharma plc Participation in Microbiome Conference

    Duncan Peyton, 4D’s Chief Executive Officer, commented: “This is an important year for 4D as we start to see clinical readouts from our lead programmes. Our focus on understanding bacterial function and mechanism to select the

    4d Pharma Plc

    How to Run With an Inflammatory Bowel Disease

    Snider has ulcerative colitis, a chronic autoimmune disease that causes inflammation and subsequent sores or ulcers in the lining of the colon which is also known as the large intestine. The condition is an inflammatory bowel